A Review of the Best Selling Pharmaceutical Drugs in 2021: 2023 Research Report
Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "A Review of the Best Selling Pharmaceutical Drugs in 2021: 2023 Research Report" report has been added to ResearchAndMarkets.com's offering.
This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021
Major players, competitive intelligence, innovative technologies, and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market.
It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe, and Japan.
An overview of the best-selling pharmaceutical drugs in 2021
Revenue forecast of the top 50 pharmaceutical drugs and assessment of their regulatory landscape
Description of the pharmaceutical drugs applications and information on pharmaceutical drugs patents
Detailed company profiles of the top 50 pharmaceutical drugs
Key Topics Covered:
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing this Study
1.3 Scope of Report
1.4.1 Primary Data and Information Gathering
1.4.2 Secondary Data and Information Gathering
1.4.3 Market Revenue Forecasts
1.5 Analyst's Credentials
1.6 Custom Research
1.7 Related Research Reports
Chapter 2 Global Pharmaceutical Drug Market
2.2 Key Strategies of Major Pharmaceutical Drugs Manufacturers
2.2.1 Distribution Network
2.2.3 Mergers and Acquisitions
2.3 Key Developments of the Major Pharmaceutical Drugs Manufacturers
2.3.1 Mergers and Acquisitions
2.3.2 Agreements, Joint Ventures, Expansions, Divestments, and Investments
2.3.3 New Product Launches and Approvals
2.4 Long-Term Outlook
Chapter 3 Regulatory Structure: Pharmaceutical Drug Market
3.1 Regulatory Background
3.2 Regulatory Systems for Biopharmaceuticals by Region
3.3 Regulatory Systems for Pharmaceuticals by Region
3.4 Regulations for Vaccines
3.4.1 Current Regulatory Issues for Vaccines
3.4.2 Moderna Vaccine Regulation in the U.K.
3.5 Key Regulatory Updates 2021
3.5.2 Medical Devices
3.6 Code of Federal Regulations (Cfr)
3.7 Good Manufacturing Practice (Gmp) Compliance
3.8 Establishment Registration
3.9 Drug Registration and Listing
3.10 Local Agent Requirements
3.10.1 Responsibilities of the U.S. Agent
Chapter 4 Pricing and Reimbursement: Pharmaceuticals and Biologics
4.1 Pricing and Reimbursement Background
4.2 Pricing and Reimbursement of Pharmaceuticals and Biologics by Region
4.3 Pricing and Reimbursement Challenges for Pharmaceuticals
4.3.1 Patented Medicines Price
4.3.2 Prices of Older Drugs
Chapter 5 Company Profiles
Alexion Pharmaceuticals Inc.
Astellas Pharma Inc.
Asahi Kasei Corp.
Bausch Health Companies Inc.
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Co.
Chugai Pharmaceutical Co. Ltd.
Daiichi Sankyo Co. Ltd.
Dr. Reddy's Laboratories Ltd.
Eisai Co. Ltd.
Eli Lilly and Co.
Endo International plc
Gilead Sciences Inc.
H. Lundbeck A/S
Johnson & Johnson Services Inc.
A. Menarini Industrie Farmaceutiche Riunite S.R.L.
Merck & Co. Inc.
Novo Nordisk A/S
Otsuka Holdings Co. Ltd.
Regeneron Pharmaceuticals Inc.
F. Hoffmann-La Roche Ltd. (Roche)
Shanghai Pharmaceuticals Holding
Shionogi & Co. Ltd.
China National Pharmaceutical Group Corp. (Sinopharm)
Stada Arzneimittel AG
Sumitomo Pharma Co. Ltd
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
Vertex Pharmaceuticals Inc.
For more information about this report visit https://www.researchandmarkets.com/r/r2zhxo
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900